SCHEMBL4302279

SCHEMBL4302279

COc1c(-c2cc3n(c2)C[C@H](C)N(C)C3)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.54
HPGD P15428 4/20 0.54
ALDH1A1 P00352 4/20 0.54
KCNH2 Q12809 3/20 0.54
HSD17B10 Q99714 2/20 0.54
POLB P06746 2/20 0.54
TDP1 Q9NUW8 2/20 0.54
PRKD3 O94806 1/20 0.54
ALOX15 P16050 1/20 0.54
OPRM1 P35372 1/20 0.54
CLK2 P49760 1/20 0.54
CLK4 Q9HAZ1 1/20 0.54
LMNA P02545 2/20 0.51
TOP2A P11388 5/20 0.49
TOP2B Q02880 5/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
GSK3B P49841 1/20 0.49
CYP2C19 P33261 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4304485 1.00 KDM4E (0.54) KDM4EHPGDALDH1A1KCNH2HSD17B10
SCHEMBL4304490 1.00 KDM4E (0.54) KDM4EHPGDALDH1A1KCNH2HSD17B10
SCHEMBL4298551 0.90 ADRB2 (0.46) KDM4EHPGDALDH1A1KCNH2HSD17B10
SCHEMBL4296299 0.90 KCNH2 (0.51) KDM4EHPGDALDH1A1KCNH2HSD17B10
SCHEMBL4296294 0.90 KCNH2 (0.51) KDM4EHPGDALDH1A1KCNH2HSD17B10
SCHEMBL4302174 0.85 KDM4E (0.62) KDM4EHPGDALDH1A1KCNH2HSD17B10
SCHEMBL4297666 0.85 KDM4E (0.62) KDM4EHPGDALDH1A1KCNH2HSD17B10
SCHEMBL4300307 0.85 KDM4E (0.62) KDM4EHPGDALDH1A1KCNH2HSD17B10
SCHEMBL4296077 0.81 KDM4E (0.59) KDM4EHPGDALDH1A1KCNH2HSD17B10
SCHEMBL4297679 0.81 KDM4E (0.57) KDM4EHPGDALDH1A1KCNH2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270379-A1 QUINOLONE DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS JANSSEN PHARMACEUTICA N.V. (BE) 2009-10-29 US claimed
US-20090270379-A1 QUINOLONE DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS JANSSEN PHARMACEUTICA N.V. (BE) 2009-10-29 US disclosed
US-20090270379-A1 QUINOLONE DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS JANSSEN PHARMACEUTICA N.V. (BE) 2009-10-29 US disclosed
US-20090270379-A1 QUINOLONE DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS JANSSEN PHARMACEUTICA N.V. (BE) 2009-10-29 US disclosed
WO-2009131973-A1 QUINOLONE DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS JANSSEN PHARMACEUTICA NV (BE) 2009-10-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270379-A1 QUINOLONE DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS NQO2, QARS1, NQO1 KDM4E 2817/4885HPGD 203/4885ALDH1A1 2331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.